134 related articles for article (PubMed ID: 30947375)
1. Exploring isoxazoles and pyrrolidinones decorated with the 4,6-dimethoxy-1,3,5-triazine unit as human farnesyltransferase inhibitors.
Lucescu L; Ghinet A; Shova S; Magnez R; Thuru X; Farce A; Rigo B; Belei D; Dubois J; Bîcu E
Arch Pharm (Weinheim); 2019 May; 352(5):e1800227. PubMed ID: 30947375
[TBL] [Abstract][Full Text] [Related]
2. New indolizine-chalcones as potent inhibitors of human farnesyltransferase: Design, synthesis and biological evaluation.
Moise IM; Ghinet A; Belei D; Dubois J; Farce A; Bîcu E
Bioorg Med Chem Lett; 2016 Aug; 26(15):3730-4. PubMed ID: 27282741
[TBL] [Abstract][Full Text] [Related]
3. A novel inhibitor of farnesyltransferase with a zinc site recognition moiety and a farnesyl group.
Tanaka A; Radwan MO; Hamasaki A; Ejima A; Obata E; Koga R; Tateishi H; Okamoto Y; Fujita M; Nakao M; Umezawa K; Tamanoi F; Otsuka M
Bioorg Med Chem Lett; 2017 Aug; 27(16):3862-3866. PubMed ID: 28666734
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of a new series of N-ylides as protein farnesyltransferase inhibitors.
Abuhaie CM; Ghinet A; Farce A; Dubois J; Rigo B; Bîcu E
Bioorg Med Chem Lett; 2013 Nov; 23(21):5887-92. PubMed ID: 24054122
[TBL] [Abstract][Full Text] [Related]
5. Phenothiazine-based CaaX competitive inhibitors of human farnesyltransferase bearing a cysteine, methionine, serine or valine moiety as a new family of antitumoral compounds.
Dumitriu GM; Bîcu E; Belei D; Rigo B; Dubois J; Farce A; Ghinet A
Bioorg Med Chem Lett; 2015 Oct; 25(20):4447-52. PubMed ID: 26372651
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and characterization of piperazinedione-based dual protein inhibitors for both farnesyltransferase and geranylgeranyltransferase-I.
Qiao Y; Gao J; Qiu Y; Wu L; Guo F; Lo KK; Li D
Eur J Med Chem; 2011 Jun; 46(6):2264-73. PubMed ID: 21440964
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors.
Kothayer H; Spencer SM; Tripathi K; Westwell AD; Palle K
Bioorg Med Chem Lett; 2016 Apr; 26(8):2030-4. PubMed ID: 26965855
[TBL] [Abstract][Full Text] [Related]
8. Novel indolizine derivatives with unprecedented inhibitory activity on human farnesyltransferase.
Dumea C; Belei D; Ghinet A; Dubois J; Farce A; Bîcu E
Bioorg Med Chem Lett; 2014 Dec; 24(24):5777-5781. PubMed ID: 25453818
[TBL] [Abstract][Full Text] [Related]
9. Thiazole- and imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase.
Bolchi C; Pallavicini M; Bernini SK; Chiodini G; Corsini A; Ferri N; Fumagalli L; Straniero V; Valoti E
Bioorg Med Chem Lett; 2011 Sep; 21(18):5408-12. PubMed ID: 21802946
[TBL] [Abstract][Full Text] [Related]
10. Farnesyltransferase inhibitors: CAAX mimetics based on different biaryl scaffolds.
Straniero V; Pallavicini M; Chiodini G; Ruggeri P; Fumagalli L; Bolchi C; Corsini A; Ferri N; Ricci C; Valoti E
Bioorg Med Chem Lett; 2014 Jul; 24(13):2924-7. PubMed ID: 24821376
[TBL] [Abstract][Full Text] [Related]
11. Peptide chemistry applied to a new family of phenothiazine-containing inhibitors of human farnesyltransferase.
Dumitriu GM; Ghinet A; Bîcu E; Rigo B; Dubois J; Farce A; Belei D
Bioorg Med Chem Lett; 2014 Jul; 24(14):3180-5. PubMed ID: 24856060
[TBL] [Abstract][Full Text] [Related]
12. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of potent FAAH inhibitors.
Tuo W; Leleu-Chavain N; Barczyk A; Renault N; Lemaire L; Chavatte P; Millet R
Bioorg Med Chem Lett; 2016 Jun; 26(11):2701-5. PubMed ID: 27117424
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis and Biological Evaluation of Isoxazole-Based CK1 Inhibitors Modified with Chiral Pyrrolidine Scaffolds.
Luxenburger A; Schmidt D; Ianes C; Pichlo C; Krüger M; von Drathen T; Brunstein E; Gainsford GJ; Baumann U; Knippschild U; Peifer C
Molecules; 2019 Mar; 24(5):. PubMed ID: 30832206
[TBL] [Abstract][Full Text] [Related]
15. Exploring isoxazole and carboxamide derivatives as potential non-nucleoside reverse transcriptase inhibitors.
Kurup SS; Joshi KA
J Mol Graph Model; 2016 Apr; 65():113-28. PubMed ID: 26973048
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of human cathepsin S by 2,4,6-trisubstituted 1,3,5-triazine analogs.
Tber Z; Wartenberg M; Jacques JE; Roy V; Lecaille F; Warszycki D; Bojarski AJ; Lalmanach G; Agrofoglio LA
Bioorg Med Chem; 2018 Aug; 26(14):4310-4319. PubMed ID: 30049585
[TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR with the aid of pharmacophore search and docking-based alignments for farnesyltransferase inhibitors.
Vaidya M; Weigt M; Wiese M
Eur J Med Chem; 2009 Oct; 44(10):4070-82. PubMed ID: 19515462
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of a new series of phenothiazine-containing protein farnesyltransferase inhibitors.
Abuhaie CM; Ghinet A; Farce A; Dubois J; Gautret P; Rigo B; Belei D; Bîcu E
Eur J Med Chem; 2013 Jan; 59():101-10. PubMed ID: 23207411
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of (5-amino-1, 2, 4-triazin-6-yl)(2-(benzo[d] isoxazol-3-yl) pyrrolidin-1-yl)methanone derivatives as sodium channel blocker and anticonvulsant agents.
Malik S; Khan SA
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):505-16. PubMed ID: 23914929
[TBL] [Abstract][Full Text] [Related]
20. Dihydrobenzisoxazole-4-one compounds are novel selective inhibitors of aldosterone synthase (CYP11B2) with in vivo activity.
Meyers K; Cogan DA; Burke J; Arenas R; Balestra M; Brown NF; Chen Z; Cerny MA; Clifford HE; Colombo F; Fader L; Frederick KS; Guo X; Goldberg D; Hornberger KR; Kugler S; Lord J; Marshall DR; Moss N; Parmentier JH; Richman JR; Schmenk J; Weldon SM; Yu M; Zhang M
Bioorg Med Chem Lett; 2018 Mar; 28(5):979-984. PubMed ID: 29254646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
